b.mwangi
Submits third-party assay reports on material purchased directly. Based in Galway.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.33%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043427 | L-Glutathione (reduced) | WXT | WXT-2605-B3833 | Medutest | 2026-Q3 | 97.67 | 6.08 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041852 | PT-141 (Bremelanotide) | GSP | GSP-2512-N3921 | Nordanalyt | 2026-Q2 | 99.62 | 5.44 | 90.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020333 | Desmopressin | GGPeps | GGPE-2511-Y3312 | Janoshik | 2025-Q4 | 99.14 | 3.50 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020144 | MOTS-c | ERP | ERP-2508-M9453 | Janoshik | 2025-Q3 | 99.68 | 2.87 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019204 | Tirzepatide | SinoPep | SNP-2502-X4903 | Medutest | 2025-Q2 | 99.02 | 6.19 | 93.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018611 | GHRP-6 | QYB | QYB-2504-H5023 | PeptideMeter | 2025-Q2 | 99.51 | 6.57 | 99.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004149 | Retatrutide | WWB | WWB-2408-X2078 | Medutest | 2024-Q4 | 99.02 | 5.78 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004729 | GHRP-6 | Homopeptide | HOMO-2407-T4218 | Janoshik | 2024-Q3 | 99.78 | 6.65 | 101.6 | Buyer-sourced | 1 | MARGINAL |